General Information of the Compound
| Compound ID |
CP0451679
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenoxy]-N-hydroxyoctanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H40N2O10
|
||||||||||||||||||
| Molecular Weight |
648.709
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](Nc2ccccc2OCCCCCCCC(=O)NO)c2cc3OCOc3cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H40N2O10/c1-42-28-14-20(15-29(43-2)34(28)39)31-21-16-26-27(47-19-46-26)17-22(21)33(23-18-45-35(40)32(23)31)36-24-10-7-8-11-25(24)44-13-9-5-3-4-6-12-30(38)37-41/h7-8,10-11,14-17,23,31-33,36,39,41H,3-6,9,12-13,18-19H2,1-2H3,(H,37,38)/t23-,31+,32-,33+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DTJYXVIPQULTRZ-HYYVTZFESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT00995, Histone deacetylase 3